Therapeutic Areas

The Science-First Full Service CRO and Consultancy for Neurology

Advance Your Novel CNS/Neurology Therapies to Approval and Commercial Success.

Second to Oncology, CNS and Neurology clinical trials are incredibly complex and complicated to navigate. At Veristat, we have assembled an extraordinary team of scientific experts who have mastered the complexities of running Neurology disease trials. In the past five years, our team has supported more than 200 clinical trials and consulting projects for neurology therapies, including neurodegenerative disorders, pain management, and mental health disorders.

Trust Veristat to guide your success in mitigating risks and efficiently bring your therapy toward its next development milestone, all while ensuring patient safety and access.

Developing a neurological therapy? Let’s talk.

Our expertise allows us to confidently handle the most complex trials and patient populations with the attention and focus needed to navigate the CNS neurology landscape.

Whatever your challenges are, Veristat provides creative and strategic approaches to inform your decision-making, mitigate trial risks, prove safety and efficacy, and achieve approval success. Our regulatory and clinical development experts are poised to launch your CNS/Neurology trial:

Pre-Clinical/Trial Planning to increase speed
Study Design and Methodology that works
Development of regulatory strategy, expedited pathways, and regulatory agency interactions
Clinical program planning, inclusive of statistical planning and analysis 
Agile patient recruitment strategies to support virtual trial and hybrid approaches
Marketing Application Preparation and Publishing
Post-Market Pharmacovigilance Ensure Safety

Case Study: Global Pediatric Full-Service Phase I/II Clinical Trial for Rare Neurological Disease Begins

A mid-sized biotech company sought Veristat early in development for help with a Natural History trial. After its successful implementation, the sponsor moved forward with the gene therapy treatment program, which has already treated its first patients. Learn how Veristat serves as an implementation arm of the sponsor and continues to provide full-service support for this Phase 1/2 clinical trial.

Neurological Disorders

Alzheimer's Disease (AD)
Amyotrophic Lateral Sclerosis
Canavan Disease
Friedreich's Ataxia
Migraine
Multiple Sclerosis (MS)
Parkinson's Disease
and more...